SHENOUDA MAGED purchased 153.1% of their position (53.43K shares) of RELMADA THERAPEUTICS, INC. on the open market
Open‑market purchase worth $149.7K — a major conviction buy. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 9/11/2024ACC: 0001213900-24-077792
+53.43K
Net shares
Net buyer
$149.7K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
53.43K acquired
Non-Derivative Transactions3
Common Stock
Direct
Shares
+8.19K
Price / share
$2.55
Trade value
$20.89K
% of position
23.5%
9/9/2024
34.90K→43.10K
Common Stock
Direct
Shares
+21.12K
Price / share
$2.73
Trade value
$57.65K
% of position
49.0%
9/10/2024
43.10K→64.22K
Common Stock
Direct
Shares
+24.12K
Price / share
$2.95
Trade value
$71.15K
% of position
37.6%
9/11/2024
64.22K→88.33K
Total
Net shares
+53.43K
Net value
$149.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2024 | P · Purchase | +8.19K | $2.55 | $20.89K | 23.5% | 34.90K | 43.10K |
| Common Stock Direct | 9/10/2024 | P · Purchase | +21.12K | $2.73 | $57.65K | 49.0% | 43.10K | 64.22K |
| Common Stock Direct | 9/11/2024 | P · Purchase | +24.12K | $2.95 | $71.15K | 37.6% | 64.22K | 88.33K |
| Total | +53.43K | $149.70K | ||||||
Derivative Transactions0
No derivative transactions reported